kabutan

PRISM BioLab, Oct-Dec (1Q) Ordinary Profit Loss Widens

Fri Feb 14, 2025 3:30 pm JST Earnings

206A PRISM BioLab Co.,LTD 【J-GAAP】

Earnings Report

PRISM BioLab Co.,LTD <206A> [TSE Growth] announced its financial results after the market closed on February 14th (15:30). The ordinary loss (non-consolidated) for the first quarter of the fiscal year ending September 2025 (October to December) expanded to a loss of 180 million yen (compared to a loss of 149 million yen in the same period last year).

In the most recent three-month period, from October to December (1Q), the operating profit/loss margin improved from -352.4% in the same period last year to -188.8%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Oct - Dec, 2024 125 -236 -180 -191 -5.3 ー Feb 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 305 -782 -831 -1,049 -33.5 0 Nov 14, 2024 J-GAAP
Sep, 2025 Guidance ー ー ー ー － 0 Nov 14, 2024 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 100 -209 -174 -233 -7.8 -209.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 90 -239 -335 -480 -15.3 -265.6 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 125 -236 -180 -191 -5.3 -188.8 Feb 14, 2025 J-GAAP
YoY － － － － －

Related Articles